- Home
- EB vs JUNS Comparison
EB vs JUNS Comparison
Compare EB & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EB
- JUNS
- Stock Information
- Founded
- EB 2008
- JUNS 2015
- Country
- EB United States
- JUNS United States
- Employees
- EB N/A
- JUNS N/A
- Industry
- EB EDP Services
- JUNS
- Sector
- EB Technology
- JUNS
- Exchange
- EB Nasdaq
- JUNS NYSE
- Market Cap
- EB 341.0M
- JUNS 281.4M
- IPO Year
- EB 2018
- JUNS 2024
- Fundamental
- Price
- EB $3.54
- JUNS $4.40
- Analyst Decision
- EB Buy
- JUNS
- Analyst Count
- EB 6
- JUNS 0
- Target Price
- EB $6.70
- JUNS N/A
- AVG Volume (30 Days)
- EB 998.5K
- JUNS 490.6K
- Earning Date
- EB 02-25-2025
- JUNS 02-11-2025
- Dividend Yield
- EB N/A
- JUNS N/A
- EPS Growth
- EB N/A
- JUNS N/A
- EPS
- EB N/A
- JUNS N/A
- Revenue
- EB $336,368,000.00
- JUNS N/A
- Revenue This Year
- EB $2.57
- JUNS N/A
- Revenue Next Year
- EB $4.11
- JUNS N/A
- P/E Ratio
- EB N/A
- JUNS N/A
- Revenue Growth
- EB 8.54
- JUNS N/A
- 52 Week Low
- EB $2.51
- JUNS $3.86
- 52 Week High
- EB $9.20
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- EB 52.65
- JUNS N/A
- Support Level
- EB $3.38
- JUNS N/A
- Resistance Level
- EB $3.73
- JUNS N/A
- Average True Range (ATR)
- EB 0.15
- JUNS 0.00
- MACD
- EB 0.01
- JUNS 0.00
- Stochastic Oscillator
- EB 63.46
- JUNS 0.00
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. It is engaged in creating a platform to enable creators to solve many challenges associated with creating live experiences. The Company's platform integrates components needed to seamlessly plan, promote and produce live events. Its platform helps to plan, promote and produce live events, thereby allowing creators to reduce friction and costs, increase reach and drive ticket sales. Geographically, it generates maximum revenue from the United States.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.